(3) Investments accounted for using the equity method
The investment in Orthomed Medizinisches Leistungs- und Rehabilitationszentrum GmbH (33.33%) with its HGB financial statements as at 31 December 2023 is reported here.
EUR ‘000 |
|
30/06/2024 |
|
30/06/2023 |
|---|---|---|---|---|
|
|
|
|
|
Non-current assets |
|
605 |
|
562 |
Current assets |
|
834 |
|
869 |
Non-current liabilities |
|
163 |
|
204 |
Current liabilities |
|
209 |
|
222 |
Net assets |
|
1,067 |
|
1,005 |
Group’s share of net assets (33.33%) |
|
356 |
|
335 |
Goodwill |
|
59 |
|
59 |
Dividends received after 31 December 2023 |
|
0 |
|
0 |
Carrying amount of interest in associate |
|
415 |
|
394 |
Revenue |
|
4,835 |
|
4,485 |
Profit/loss from continuing operations |
|
62 |
|
46 |
Comprehensive income (33.33%) |
|
21 |
|
15 |
Group’s share of comprehensive income |
|
21 |
|
15 |
EUR ‘000 |
|
2023 |
|
2022 |
|---|---|---|---|---|
|
|
|
|
|
Cash flows from operating activities |
|
122 |
|
-6 |
Cash flows from investing activities |
|
-162 |
|
-149 |
Cash flows from financing activities |
|
-49 |
|
35 |
Net change in cash and cash equivalents |
|
-89 |
|
-120 |